HeartBeam's Arrhythmia Assessment System Gains FDA 510(k) Clearance

Yahoo FinanceDec 17 17:30

HeartBeam Stock Slips 15%

RTTNewsDec 17 00:42

HeartBeam Shares Are Trading Higher After the FDA Granted the Company 510(k) Clearance of Its System for Comprehensive Arrhythmia Assessment.

BenzingaDec 16 21:35

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

BusinesswireDec 16 21:31

HeartBeam Unveils Data At AHA 2024 For Portable Credit Card-Sized ECG Device; Studies Demonstrate Comparable Arrhythmia Detection To Standard ECGs And Highlight Remote Chest Pain Evaluation To Reduce Heart Attack Care Delays

BenzingaNov 19 21:32

HeartBeam Announces Positive Data From Two Studies at Prestigious American Heart Association Conference

BusinesswireNov 19 21:31